Vanguard Group Inc Supernus Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,205,256 shares of SUPN stock, worth $298 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,205,256

Previous 6,163,892 0.67%

Holding current value

$298 Million

Previous $202 Million 3.11%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$30.29 - $33.43 $1.25 Million - $1.38 Million	41,364 Added 0.67%	6,205,256 $196 Million
Q1 2025 May 09, 2025	BUY	$31.17 - $40.0 $409,355 - $525,320	13,133 Added 0.21%	6,163,892 $202 Million
Q4 2024 Feb 11, 2025	BUY	$31.89 - $37.83 $728,750 - $864,491	22,852 Added 0.37%	6,150,759 $222 Million
Q3 2024 Nov 13, 2024	SELL	$25.77 - $35.16 $248,268 - $338,731	-9,634 Reduced 0.16%	6,127,907 $191 Million
Q2 2024 Aug 13, 2024	SELL	$25.99 - $33.85 $1.8 Million - $2.34 Million	-69,273 Reduced 1.12%	6,137,541 $164 Million
Q1 2024 May 10, 2024	SELL	$27.11 - $35.17 $214,629 - $278,440	-7,917 Reduced 0.13%	6,206,814 $212 Million
Q4 2023 Feb 14, 2024	BUY	$22.72 - $29.68 $3.24 Million - $4.23 Million	142,551 Added 2.35%	6,214,731 $180 Million
Q3 2023 Nov 14, 2023	BUY	$27.57 - $32.91 $791,562 - $944,879	28,711 Added 0.48%	6,072,180 $167 Million
Q2 2023 Aug 14, 2023	BUY	$29.91 - $38.73 $4.86 Million - $6.29 Million	162,404 Added 2.76%	6,043,469 $182 Million
Q1 2023 May 15, 2023	BUY	$34.93 - $42.03 $3.18 Million - $3.83 Million	91,105 Added 1.57%	5,881,065 $213 Million
Q4 2022 Feb 10, 2023	BUY	$31.09 - $37.88 $3.41 Million - $4.16 Million	109,718 Added 1.93%	5,789,960 $207 Million
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $1.72 Million - $2.12 Million	59,794 Added 1.06%	5,680,242 $192 Million
Q2 2022 Aug 12, 2022	BUY	$25.33 - $34.25 $2.07 Million - $2.8 Million	81,628 Added 1.47%	5,620,448 $163 Million
Q1 2022 May 13, 2022	BUY	$28.51 - $32.9 $731,880 - $844,575	25,671 Added 0.47%	5,538,820 $179 Million
Q4 2021 Feb 14, 2022	BUY	$26.37 - $34.22 $933,656 - $1.21 Million	35,406 Added 0.65%	5,513,149 $161 Million
Q3 2021 Nov 12, 2021	SELL	$23.54 - $31.39 $157,270 - $209,716	-6,681 Reduced 0.12%	5,477,743 $146 Million
Q2 2021 Aug 13, 2021	BUY	$26.72 - $33.19 $147 Million - $182 Million	5,484,424 New	5,484,424 $169 Million

Others Institutions Holding SUPN

# of Institutions

312

Shares Held

61.7M

Call Options Held

18.4K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.57B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Supernus Pharmaceuticals, Inc. Transaction History